Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 25 EP applications Marcus Jonathan William Dalton has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11721756

NOVEL PROCESS

IPC classification:
C08B 37/00, C12P 19/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11724201

NOVEL PROCESS

IPC classification:
A61K 9/00, A61K 9/107, A61K 39/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11724202

NOVEL PROCESS

IPC classification:
A61K 9/00, A61K 9/107, A61K 39/00, A61K 47/06, A61K 47/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12723216

INACTIVATED DENGUE VIRUS VACCINE

IPC classification:
A61K 39/12, A61K 47/10
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP12713175

FERMENTATION PROCESS

IPC classification:
A61K 39/02, C07K 14/195, C07K 14/34, C12P 21/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP12771540

FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A

IPC classification:
A61K 39/145, A61K 39/385, A61P 31/16, A61P 37/04, C07K 14/285, C07K 19/00, C12N 15/00, C12P 21/02
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP11707193

IMMUNOGENIC COMPOSITION

IPC classification:
A61K 39/095, A61K 39/116, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP11707192

IMMUNOGENIC COMPOSITION

IPC classification:
A61K 39/095, A61K 39/116, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Michael John Lubienski, GlaxoSmithKline Intellectual Property Management Limited
Status:
EXAMINATION REQUESTED
EP11757268

VACCINE AGAINST N. MENINGITIDIS

IPC classification:
A61K 39/095
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12794675

VACCINE COMPRISING A TLR-5 AGONIST AS ADJUVANT FOR USE IN CUTANEOUS IMMUNISATION

IPC classification:
A61K 39/29, A61K 39/39, A61P 31/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12791145

VACCINE

IPC classification:
A61K 39/29, A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12772735

LIPOSOME PRODUCTION USING ISOPROPANOL

IPC classification:
A61K 9/127, A61K 47/36
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP12707745

PROCESS FOR CONJUGATION OF BACTERIAL ANTIGEN TO A CARRIER PROTEIN

IPC classification:
A61K 39/02, A61K 47/48, A61P 31/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13742207

PROCESS FOR THE PURIFICATION OF SAPONINS

IPC classification:
C07H 1/08, C07H 15/256
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13811876

CONJUGATES FOR PROTECTING AGAINST DIPHTHERIA AND/OR TETANUS

IPC classification:
A61K 39/00, C07H 1/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14704537

INTRADERMAL DELIVERY OF IMMUNOLOGICAL COMPOSITIONS COMPRISING TOLL-LIKE RECEPTOR AGONISTS

IPC classification:
A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14705488

PHARMACEUTICAL COMPOSITIONS COMPRISING VESICLES

IPC classification:
A61K 9/50
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP14700602

CYCLOALKYNE DERIVATIZED SACCHARIDES

IPC classification:
A61K 38/00, A61K 47/48, C08B 37/00
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14709704

RNA PURIFICATION METHODS

IPC classification:
C12N 15/09
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP15182862

NEISSERIAL ANTIGENIC PEPTIDES

IPC classification:
A61K 39/095, A61K 39/40, A61K 48/00, C07K 14/22, C07K 16/12, C12N 15/31, G01N 33/53, G01N 33/569
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11708449

VACCINE COMPOSITION

IPC classification:
A61K 39/095, A61K 39/116, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Michael John Lubienski, GlaxoSmithKline Intellectual Property Management Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11716419

METHOD FOR INACTIVATING INFLUENZA VIRUS

IPC classification:
A61K 39/12, A61K 39/145, C12N 7/06
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
PATENT GRANTED
EP11700859

MODIFIED TUBERCULOSIS ANTIGENS

IPC classification:
A61K 39/04, C07K 14/35
Applicant:
Glaxo Group Limited
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
PATENT GRANTED
EP11776775

IMMUNOGENIC COMPOSITIONS AND METHODS FOR TREATING NEUROLOGIC DISORDERS

IPC classification:
A61K 31/00, A61K 31/7008, A61K 31/7056, A61K 39/00, A61K 39/39, A61K 39/395, A61P 25/28
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
PATENT GRANTED
EP15713532

NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE

IPC classification:
A61K 39/002, A61K 39/015, A61K 39/29, A61K 39/39
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature